Literature DB >> 21393868

Immunoglobulin M nephropathy nephropathy in adults and adolescents in India: a single-center study of natural history.

A M Singhai1, A V Vanikar, K R Goplani, K V Kanodia, R D Patel, K S Suthar, H V Patel, M R Gumber, P R Shah, H L Trivedi.   

Abstract

BACKGROUND: Immunoglobulin M nephropathy (IgMN) is an idiopathic glomerulonephritis (GN) usually presenting clinically as steroid resistant/dependent nephrotic syndrome (NS) with pathology of mesangial proliferative GN or focal and segmental glomerulosclerosis with diffuse predominant mesangial IgM deposits. Not much information is available about its natural history. This is the first Indian study to our knowledge on IgMN in adults and adolescents.
MATERIALS AND METHODS: We evaluated renal biopsies performed at our center between January,'04 to September,'09. Biopsies of all adolescents and adults were evaluated for IgMN and we studied their age, gender distribution, blood pressure (BP), disease duration, steroid/immunosuppressive management and serial serum creatinine (SCr), urinary proteins, and BP values. Patients with other systemic diseases/infections and children were excluded.
RESULTS: IgMN constituted 4.3% of 2702 adult renal biopsies. No significant gender predilection was noted. Males presented at average age of 23.1 years, females at 30 years. Steroid-dependent NS was the commonest presentation noted in 75% followed by steroid-resistant NS. Hypertension was noted in 10% patients. Mesangial proliferative GN (MePGN) was commonest histopathological finding noted in 74.4%, followed by focal segmental glomerulosclerosis (FSGS) in 16.2%, and minimal change disease (MCD) in 9.4% biopsies. Sole IgM deposits were noted in 88.5%. All MCD, 35.6% MePGN reached remission, FSGS progressed to renal failure by 1 year. Hypertension, proteinuria, interstitial fibrosis, and FSGS were bad prognosticators.
CONCLUSIONS: This is the first Indian study of IgMN in adults and adolescents carried out over a period of 5.8 years, which has shown that hypertension, proteinuria, and interstitial fibrosis at presentation have bad prognosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393868     DOI: 10.4103/0377-4929.77315

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  9 in total

1.  Comment on: IgM nephropathy: Can we still ignore it.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2013-10-01

2.  IgM nephropathy; time to act.

Authors:  Muhammed Mubarak
Journal:  J Nephropathol       Date:  2014-01-01

Review 3.  IgM nephropathy; can we still ignore it.

Authors:  Aruna Vanikar
Journal:  J Nephropathol       Date:  2013-04-01

Review 4.  IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

Authors:  R Brugnano; R Del Sordo; C Covarelli; E Gnappi; S Pasquali
Journal:  J Nephrol       Date:  2016-02-03       Impact factor: 3.902

5.  The spectrum of histopathological lesions in children presenting with steroid-resistant nephrotic syndrome at a single center in Pakistan.

Authors:  Muhammed Mubarak; Javed I Kazi; Shaheera Shakeel; Ali Lanewala; Seema Hashmi
Journal:  ScientificWorldJournal       Date:  2012-05-02

6.  IgM nephropathy: timely response to a call for action.

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2013-11-02

7.  IgM mesangial deposition as a risk factor for relapses of adult-onset minimal change disease.

Authors:  Cheng-Wen Yang; Fan-Yu Chen; Fu-Pang Chang; Yang Ho; Bo-Sheng Wu; An-Hang Yang; Der-Cherng Tarng; Chih-Yu Yang
Journal:  BMC Nephrol       Date:  2021-01-12       Impact factor: 2.388

8.  The natural history of immunoglobulin M nephropathy in adults.

Authors:  Thomas M Connor; Valeria Aiello; Megan Griffith; Thomas Cairns; Candice A Roufosse; H Terence Cook; Charles D Pusey
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

9.  IgM nephropathy revisited.

Authors:  Muhammed Mubarak; Javed I Kazi
Journal:  Nephrourol Mon       Date:  2012-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.